Literature DB >> 10970053

Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins.

A Tandon1, E Rogaeva, M Mullan, P H St George-Hyslop.   

Abstract

Alzheimer's disease is the most common neurodegenerative disorder of aging, accounting for an estimated two-thirds of all cases of senile dementia. Epidemiologic studies have failed to resolve any single cause of Alzheimer's disease and suggest a complex etiology, with environmental and genetic factors influencing the pathogenesis. Although the majority of cases are sporadic, a small number display familial clustering. Genetic analyses of these pedigrees have identified four genes that are involved in the development of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970053     DOI: 10.1097/00019052-200008000-00003

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  18 in total

1.  A novel presenilin 1 mutation (L282F) in familial Alzheimer's disease.

Authors:  Tsuyoshi Hamaguchi; Akiyoshi Morinaga; Tamao Tsukie; Ryozo Kuwano; Masahito Yamada
Journal:  J Neurol       Date:  2009-05-09       Impact factor: 4.849

Review 2.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

3.  A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity.

Authors:  Elizabeth A Heilig; Weiming Xia; Jie Shen; Raymond J Kelleher
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

Review 4.  The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.

Authors:  Ekaterina Rogaeva
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

5.  Association between interleukin-1α C(-889)T polymorphism and Alzheimer's disease: a meta-analysis including 12,817 subjects.

Authors:  Bing-Hu Li; Li-Li Zhang; Yan-Wei Yin; Yan Pi; Lu Guo; Qing-Wu Yang; Chang-Yue Gao; Chuan-Qin Fang; Jing-Zhou Wang; Jing Xiang; Jing-Cheng Li
Journal:  J Neural Transm (Vienna)       Date:  2012-07-28       Impact factor: 3.575

6.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

Authors:  Pinar E Coskun; M Flint Beal; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

7.  Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.

Authors:  F E Harrison; J Allard; R Bixler; C Usoh; L Li; J M May; M P McDonald
Journal:  Nutr Neurosci       Date:  2009-10       Impact factor: 4.994

8.  High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients.

Authors:  Laila Abdullah; Cheryl Luis; Daniel Paris; Ghania Ait-ghezala; Benoit Mouzon; Elizabeth Allen; Julia Parrish; Myles A Mullan; Scott Ferguson; Marcie Wood; Fiona Crawford; Michael Mullan
Journal:  Mol Med       Date:  2009-12-08       Impact factor: 6.354

Review 9.  Genetics of the dementias.

Authors:  J M Schott; N C Fox; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

10.  Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease.

Authors:  Alessandra Pani; Antonella Mandas; Giacomo Diaz; Claudia Abete; Pier Luigi Cocco; Fabrizio Angius; Annalisa Brundu; Nico Muçaka; Maria Elena Pais; Antonio Saba; Luigi Barberini; Cristina Zaru; Manuela Palmas; Paolo F Putzu; Alessandra Mocali; Francesco Paoletti; Paolo La Colla; Sandra Dessì
Journal:  BMC Med       Date:  2009-11-02       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.